No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin. [electronic resource]
Producer: 20060227Description: 101 p. digitalISSN:- 1471-2407
- Antineoplastic Agents -- pharmacology
- Antineoplastic Agents, Phytogenic -- pharmacology
- Base Pair Mismatch
- Cisplatin -- therapeutic use
- DNA Repair
- DNA Replication
- Drug Resistance, Neoplasm
- Exons
- Female
- Humans
- Microsatellite Repeats -- genetics
- Mutation
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- therapeutic use
- Polymerase Chain Reaction
- Sequence Analysis, DNA
- Tubulin -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.